United States · Funded startup

Who invested in In8bio

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 11 months ago

Funding summaryUpdated 15 Nov 2026

$20Mraised across 1 round since 2025, from 1 source

Latest round
Round, $20MDec 2025
Investors
0
See who backed them

The rounds

  1. Dec 2025
    Round$20M

    No investor was named in the report.

    Filed with the SEC (Form D); no report of this raise yetSEC filing: $20M sold, first sale Dec 2025

Funding filed with regulators

In8bio filed 4 raises, $82M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Dec 2025$20M17 investorsof $40M offeredSEC Form D
  2. Oct 2024$12M73 investorsSEC Form D
  3. Dec 2023$14M20 investorsequity, optionsSEC Form D
  4. May 2018$35M33 investorsequitySEC Form D

Founders and team

From In8bio's own website: 1 founder, 2 on the team.

William HoChief Executive Officer and Co-Founder
  • Stacey BilinskiVice President, Clinical Operations
  • Patrick McCallChief Financial Officer

Quick answers about In8bio

How much has In8bio raised?

In8bio has raised $20M across 1 round since 2025.

When did In8bio last raise?

In8bio's most recent round, $20M, was in Dec 2025.

What was In8bio's biggest round?

Its most recent round, $20M in Dec 2025, is also its largest on record.

Where is In8bio based?

In8bio is based in the United States.

Companies like In8bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.